Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection

Abstract

IMPORTANCEEhrlichiosis cases in the US have increased more than 8-fold since 2000. Up to 57% of patients with ehrlichiosis require hospitalization and 11% develop a life-threatening complication; however, risk factors for serious disease are not well documented. OBJECTIVE To examine risk factors associated with severe ehrlichiosis. DESIGN, SETTING, AND PARTICIPANTS An analytic cross-sectional study of patients diagnosed with ehrlichiosis by polymerase chain reaction (PCR) between January 1, 2007, and December 31, 2017, was conducted in a single tertiary-care center in a region endemic for ehrlichiosis. Analysis was performed from February 27, 2018, to September 9, 2020. A total of 407 positive Ehrlichia PCR results were identified from 383 unique patients, with 155 unique patients meeting study criteria. Patients hospitalized at other institutions who had a positive Ehrlichia PCR performed as a reference test (n = 222) were excluded as no clinical data were available. Electronic medical record review was performed to collect demographic, clinical, laboratory, treatment, and outcomes data. Cases were excluded when there were insufficient clinical data to assess the severity of illness (n = 3) and when the clinical illness did not meet the case definition for ehrlichiosis (n = 3). EXPOSURES Date of presentation, onset of symptoms, date of PCR testing, date of treatment initiation, site of care, age, birth sex, race/ethnicity, Charlson Comorbidity Index, trimethoprim with sulfamethoxazole use within the prior 2 weeks, and immunosuppression. MAIN OUTCOMES AND MEASURES Requirement for intensive care unit (ICU) admission. RESULTSOf the 155 patients who met inclusion criteria, 99 patients (63.9%) were men, and 145 patients (93.5%) identified as non-Hispanic White; median age was 50 years (interquartile range, 23-64 years). Intensive care unit admission was indicated in 43 patients (27.7%), 94 patients (60.6%) were hospitalized on general medical floors, and 18 patients (11.6%) received care as outpatients. In adjusted analysis, time to treatment initiation was independently associated with an increased risk for ICU admission (adjusted prevalence ratio [aPR], 1.09; 95% CI, 1.04-1.14; P < .001). Documentation of tick exposure was independently associated with a decreased risk for ICU admission (aPR, 0.54; 95% CI, 0.34-0.86; P = .01). There appeared to be a nonsignificant change toward a decreased need for ICU care among immunosuppressed persons (aPR, 0.51; 95% CI, 0.26-1.00; P = .05). CONCLUSIONS AND RELEVANCEThis study suggests that delay in initiation of doxycycline therapy is a significant factor associated with severe ehrlichiosis. Increased recognition of infection by frontline clinicians to promote early treatment may improve outcomes associated with this increasingly common and life-threatening infection.

Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients

“…Transplant type has been associated with worse outcomes and more prolonged ICU admissions, with lung transplant being associated with a poorer prognosis compared with other solid organ transplants [ 10 , 24 ]. The case fatality rate has been reported between 0% and 26% for transplant patients, which is similar to the case fatality rate in all HME cases [ 8 – 10 ]. Case fatality has decreased since its discovery despite the number of cases increasing [ 1 ].…”

“…Early detection of disease is crucial to prevent disease progression and end-organ damage. In one study, delayed time to treatment was associated with the need for ICU admission [ 8 ]. In this case, delays in the patient's diagnosis led to renal failure requiring hemodialysis and septic shock requiring vasopressor support.…”

“…Immunosuppression has often been suggested as a possible risk factor for worse prognosis and ICU admission, but the data are mixed. One study found that immunosuppression was associated with decreased need for ICU admission, while others showed that it was associated with more severe disease [ 8 , 10 , 23 ]. Transplant type has been associated with worse outcomes and more prolonged ICU admissions, with lung transplant being associated with a poorer prognosis compared with other solid organ transplants [ 10 , 24 ].…”

“Half the truth is often a great lie:” testing for tick-borne diseases and implications for surveillance

“…Without new testing methodologies or rigorous protocols to ensure high levels of testing completeness, estimates of disease incidence will remain susceptible to both under-and over-representation, the magnitude of which is ill-defined. Perhaps more importantly, misunderstanding of the predictive value of test results, especially a negative acute result, may contribute to delays in diagnosis and treatment, which is one of the main risk factors for severe disease and death (18)(19)(20).…”

An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection

“…Human monocytic ehrlichiosis (HME), one of the most prevalent, life-threatening, and emerging tick-borne diseases in the United States ( 1 , 2 ) is caused by infection with Ehrlichia chaffeensis , an obligatory intracellular bacterium in the order Rickettsiales. E. chaffeensis replicates within human monocytes-macrophages and causes severe flu-like symptoms accompanied by hematologic abnormalities and hepatitis.…”